Gradientech: Hilja Ibert, Nedal Safwat

Gradientech has appointed Hilja Ibert and Nedal Safwat to its board, effective May 9. Ted Elvhage and Simon Turner chose not to run for reelection to the board, the Swedish rapid antibiotic susceptibility testing firm said. Ibert has more than 30 years of experience in the clinical diagnostics industry and has worked at Hologic, Becton Dickinson, and BioMérieux. She is currently CEO of Gentian Diagnostics. Safwat is the VP and head of molecular diagnostics North America at Qiagen. He was previously at BioMérieux and covered microbiology applications such as bacteria identification, antibiotic susceptibility testing, antibiotic resistance, and sepsis detection products.